Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Baker Felix
Relationship:   Director, 10% Owner
City:  
State:  
   
Insider Summary:
  
   
Companies Owned :   20    
Direct Shares   927,207    

Indirect Shares

  141,861,898      
Direct Value   $81,660,525    

Indirect Value

  $12,932,114,466      
Total Shares   142,789,105      
Total Value   $13,013,774,992      


Incyte Corp
 $32,141,876 Seagen Inc
 $49,182,531 Synageva BioPharma Corp
 $0 Genomic Health Inc
 $18,271 Biocryst Pharmaceuticals Inc
 $301,214 Neurogene
 $16,634 Incyte Corp
 $32,141,876 Seagen Inc
 $49,182,531 Synageva BioPharma Corp
 $0 Genomic Health Inc
 $18,271 Biocryst Pharmaceuticals Inc
 $301,214 Neurogene
 $16,634
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    36   
    6    

     Stock price went up :

    15   
    6    
     Stock price went down :
    21   
    0    
   
     Gain/Loss Ratio :
   0.0   
   6.0   
     Percentage Gain/Loss :
   -24.3%
 18.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Incyte Corp INCY Director, 10% Owner 2023-09-29 559,963 2023-09-29 33,480,292    Premium*  
            Ardea Biosciences Inc RDEA Director, 10% Owner 2003-10-06 0 2012-02-01 116,454    Premium*  
            Seagen Inc SGEN Director, 10% Owner 2018-02-01 215,015 2018-02-01 44,355,335    Premium*  
            Synageva BioPharma Corp GEVA Director, 10% Owner 2015-06-22 100,503 2015-06-22 9,328,233    Premium*  
            Viropharma Inc VPHM 10% Owner 2005-01-31 0 2011-12-14 303,264    Premium*  
            Aceragen, Inc ACGN Director 0 2017-07-03 145,453    Premium*  
            Tapestry Pharmaceuticals Inc TPPHQ 10% Owner 0 2008-10-15 0    Premium*  
            Genomic Health Inc GHDX Director, 10% Owner 2012-10-01 288 2012-10-01 11,377,485    Premium*  
            Allos Therapeutics Inc ALTH 10% Owner 0 2009-02-06 1,629    Premium*  
            Biocryst Pharmaceuticals Inc BCRX 10% Owner 2016-08-16 46,918 2016-08-16 9,418,390    Premium*  
            Heron Therapeutics Inc HRTX 10% Owner 0 2011-06-30 5,266,568    Premium*  
            Adolor Corp ADLR 10% Owner 2010-04-26 0 2011-12-19 0    Premium*  
            Diadexus Inc DDXS 10% Owner 0 2010-07-28 140,525    Premium*  
            Pharmacyclics Inc PCYC 10% Owner 0 2011-08-22 1,809    Premium*  
            Ocera Therapeutics Inc OCRX 10% Owner 2012-03-12 0 2012-03-14 57,704    Premium*  
            XOMA Corporation XOMA Director, 10% Owner 2012-10-29 0 2012-10-29 480,639    Premium*  
            Neurogene NGNE 10% Owner 2015-08-07 4,520 0    Premium*  
            Invitae Corp NVTA 10% Owner 0 2015-08-27 6,554,967    Premium*  
            Bellicum Pharmaceuticals, Inc BLCM 10% Owner 0 2015-12-24 4,865,647    Premium*  
            Kodiak Sciences Inc. KOD Director, 10% Owner 2022-01-21 0 2022-06-06 15,967,504    Premium*  
* Premium Members only  

Records found :    1397         Free Registration Required For Full Results.    Limit: 25

Download
  Page 37 of 56
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
KOD Kodiak Sciences Inc. Director   –       •       •   2022-05-17 4 B $5.99 $663,571 I/I 110,824 14,942,601 2.25 %
KOD Kodiak Sciences Inc. Director   –       •       •   2022-05-18 4 B $5.95 $1,335,419 I/I 223,766 15,142,074 2.25 %
KOD Kodiak Sciences Inc. Director   –       •       •   2022-05-25 4 B $6.53 $664,135 I/I 101,144 15,232,546 2.25 %
KOD Kodiak Sciences Inc. Director   –       •       •   2022-05-26 4 B $6.71 $628,583 I/I 93,322 15,316,021 2.25 %
KOD Kodiak Sciences Inc. Director   –       •       •   2022-05-27 4 B $6.64 $1,071,030 I/I 155,940 15,455,507 2.25 %
KOD Kodiak Sciences Inc. Director   –       •       •   2022-06-02 4 B $7.51 $1,274,594 I/I 166,232 15,604,214 2.25 %
KOD Kodiak Sciences Inc. Director   –       •       •   2022-06-03 4 B $7.93 $812,481 I/I 102,200 15,695,640 2.25 %
KOD Kodiak Sciences Inc. Director   –       •       •   2022-06-06 4 B $7.75 $2,361,093 I/I 303,917 15,967,504 2.25 %
NGNE Neurogene 10% Owner   –       –       •   2015-08-07 3/A IO $0.00 $0 D/D 0 4,520 -
OCRX Ocera Therapeutics Inc 10% Owner   –       –       •   2012-03-12 4 B $1.87 $61,629 I/I 25,304 51,126 1.5 -
OCRX Ocera Therapeutics Inc 10% Owner   –       –       •   2012-03-12 3 IO $0.00 $0 I/I 0 25,822 -
OCRX Ocera Therapeutics Inc 10% Owner   –       –       •   2012-03-12 3 IO $0.00 $0 I/I 0 110,030 -
OCRX Ocera Therapeutics Inc 10% Owner   –       –       •   2012-03-12 4 B $1.87 $229,685 I/I 94,306 204,336 1.5 -
OCRX Ocera Therapeutics Inc 10% Owner   –       –       •   2012-03-13 4 B $2.96 $46,143 I/I 15,599 219,935 1.5 -
OCRX Ocera Therapeutics Inc 10% Owner   –       –       •   2012-03-13 4 B $2.96 $12,383 I/I 4,186 55,312 1.5 -
OCRX Ocera Therapeutics Inc 10% Owner   –       –       •   2012-03-14 4 B $2.99 $36,172 I/I 12,076 232,011 1.5 -
OCRX Ocera Therapeutics Inc 10% Owner   –       –       •   2012-03-14 4 B $2.99 $7,165 I/I 2,392 57,704 1.5 -
PCYC Pharmacyclics Inc 10% Owner   –       –       •   2011-08-22 3 IO $0.00 $0 I/I 0 1,809 -
SGEN Seagen Inc Director   –       •       •   2004-08-02 4 B $5.89 $11,999 I/I 2,010 2,010 2.17 -
SGEN Seagen Inc Director   –       •       •   2004-08-02 4 B $5.89 $59,810 I/I 10,019 10,019 2.25 -
SGEN Seagen Inc Director   –       •       •   2004-08-02 4 B $5.89 $63,106 I/I 10,571 10,571 2.25 -
SGEN Seagen Inc Director   –       •       •   2004-08-03 4 B $5.71 $14,840 I/I 2,598 4,608 2.17 -
SGEN Seagen Inc Director   –       •       •   2004-08-03 4 B $5.71 $73,984 I/I 12,952 22,971 2.25 -
SGEN Seagen Inc Director   –       •       •   2004-08-03 4 B $5.71 $78,057 I/I 13,665 24,236 2.25 -
SGEN Seagen Inc Director   –       •       •   2004-08-04 4 B $5.58 $17,562 I/I 3,148 7,756 2.17 -

  1397  Records found
  1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20   21   22   23   24   25   26   27   28   29   30   31   32   33   34   35   36   37  38   39   40   41   42   43   44   45   46   47   48   49   50   51   52   53   54   55   56      
  Page 37 of 56  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed